Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
1(11%)
Results Posted
25%(1 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_1
3
33%
Ph phase_4
1
11%
Ph not_applicable
3
33%
Ph phase_2
2
22%

Phase Distribution

3

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
3(33.3%)
Phase 2Efficacy & side effects
2(22.2%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(4)
Terminated(3)
Other(1)

Detailed Status

Completed4
Withdrawn2
Terminated1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (33.3%)
Phase 22 (22.2%)
Phase 41 (11.1%)
N/A3 (33.3%)

Trials by Status

terminated111%
withdrawn222%
completed444%
recruiting111%
unknown111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
OTHER
Total Trials
9